Claris

Menu
  • About Us
    • Company Overview
    • Milestones
  • Investors
    • Financials
    • Corporate Governance
    • Board of Directors' Profile
    • Shareholding Pattern
    • Notices/ Results
    • Registrar & Transfer Agent
    • Investor Contact
    • Unclaimed Dividend
    • Policies and Codes
    • Letter of appointment to Independent Directors
  • Media
    • Press Room
    • Media Contact
    • Media Gallery
  • Career
    • Overview
    • Culture
    • Current Openings
    • Apply
  • Contact Us
  • Claris Lifesciences Limited
  • Media
  • Press Room 2019
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012
    • 2011
    • 2010
    • 2009
    • 2008
  • Media Contact
  • Media Gallery

Press Room 2015

December
Financial Update for the quarter ended December 31, 2015


September
Financial Update for the quarter ended September 30, 2015


August
Unaudited Financial Results for the Quarter ended June 30, 2015

Claris Lifesciences Limited receives Prior Approval Supplement for Furosemide Injection in US

Income Tax Authorities - Search / Survey


July
Pharm Exec recognises Mr. Arjun Handa, Vice Chairman & MD in 'Emerging Pharma Leaders 2015'


May
The Economic Times Ascent features article of Claris' President - HRM & Corp. Communication

The Economic Times Ascent features article of Claris' President - HRM & Corp. Communication



Audited Financial results for the quarter and financial year (Fifteen Months) ended 31st March 2015


April
Claris Lifesciences Limited receives supplemental ANDA approval for Fluconazole injection in 50ml PVC Bags

Claris Lifesciences Limited announces settlement of litigations and license agreement for its generic DIPRIVAN in USA


March
Ind-Ra affirms ‘IND A’ rating to Claris


February
Unaudited Financial Results for the Quarter ended 31st December, 2014


January
Half Marathon Amdavad, powered by Claris, concludes on a high note

Half Marathon Amdavad, powered by Claris, concludes on a high note

Half Marathon Amdavad, powered by Claris, concludes on a high note


What’s New?

  • Claris completes sale of its Global Generic Injectables Business to Baxter
  • Financials
  • Notices/ Results
  • Annual Report 2016-17
Claris ClarisClaris
Useful Links
  • Home
  • About Us
  • Career
  • Contact Us
Investors
  • Financials
  • Board of Directors' Profile
  • Investor Contact
  • Policies and Codes
Media
  • Press Room
  • Media Contact
  • Media Gallery
India

Registered and Corporate Office:
Claris Corporate Headquarters
Nr. Parimal Crossing, Ellisbridge,
Ahmedabad - 380 006,
India.
Tel : + 91-79-26563331
CIN : U85110GJ1994PLC022543

  • Claris Lifesciences Ltd. All Rights Reserved.
  • Terms of Use
  • Privacy Policy